654
Registered trials
297
Recruiting
292
Completed trials
216
Sponsors active
122
Research sites
Phase III:
312
Phase II/III:
38
Phase II:
173
Phase I/II:
37
Phase III/IV:
6
Phase IV:
52
Phase I:
9
Phase I (Other):
19
Phase I (FiH):
7
Other:
1
Oversight events in trials active here:
43 serious breaches
171 temporary halts
11 urgent safety measures
19 unexpected events
27 corrective measures
across 88 trials
View oversight register →
Top conditions
Non-small cell lung cancer
11
Crohn's disease
7
Colitis ulcerative
6
Plasma cell myeloma refractory
6
Glioblastoma
6
Prostate cancer metastatic
5
Fabry´s disease
5
Ovarian cancer
5
Hepatocellular carcinoma
4
Chronic obstructive pulmonary disease
4
Myelodysplastic syndrome
4
Squamous cell carcinoma of head and neck
4
Top sponsors
Oslo University Hospital HF
73
Merck Sharp & Dohme LLC
43
Helse Bergen HF
26
Boehringer Ingelheim International GmbH
21
AstraZeneca AB
18
Boehringer Ingelheim Espana S.A.
18
Sanofi-Aventis Recherche & Developpement
18
Novartis Pharma AG
16
St. Olavs Hospital HF
16
Celgene Corp.
12
Glaxosmithkline Research & Development Limited
12
Janssen - Cilag International
12
Cities with most trials
All 59 cities →All trials — page 7
654 totalShowing 145–168 of 654 trials